Importer of Controlled Substances Registration: Meridian Medical Technologies, 40780 [2014-16318]
Download as PDF
<![CDATA[
40780
Federal Register / Vol. 79, No. 134 / Monday, July 14, 2014 / Notices
Collection Request. Calculated estimates
for an SRS respondent to respond
indicate 7 minutes per quarter. The total
annual burden hour per respondent is
28 minutes. Total Annual Hour Burden:
7 minutes × 4 quarters = 28 minutes.
6. An estimate of the total public
burden (in hours) associated with the
collection: There are approximately
5,300 hours, annual burden, associated
with this information collection.
11,357 respondents × 4 responses/year =
45,428 total annual responses.
45,428 × 7 minutes/60 minutes = 5,300
total annual hour burden.
(This burden estimate does not include
the 6,933 NIBRS agencies; the NIBRS
burden hours are captured in the NIBRS
Information Collection Request.)
If additional information is required
contact: Jerri Murray, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., 3E.405,
Washington, DC 20530.
Dated: July 9, 2014.
Jerri Murray,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2014–16383 Filed 7–11–14; 8:45 am]
BILLING CODE 4410–02–P
DEPARTMENT OF JUSTICE
mstockstill on DSK4VPTVN1PROD with NOTICES
Notice of Lodging of Proposed
Modification of Amended Consent
Decree Under The Clean Air Act
On July 8, 2014, the Department of
Justice lodged a proposed Third
Amended Consent Decree with the
United States District Court for the
Eastern District of Wisconsin in the
lawsuit entitled United States and
Michigan Department of Environmental
Quality, Plaintiffs, and Clean
Wisconsin, Sierra Club, and Citizens’
Utility Board, Intervenors, v. Wisconsin
Electric Power Company, Civil Action
No. 03-c-0371.
Generally, the proposed modifications
to the Decree are designed: (1) To
accommodate the voluntary decision of
the Defendant, Wisconsin Electric
Power Company (‘‘WE Energies,’’ ‘‘WE’’
or ‘‘Defendant’’), to convert all four coalfired boilers at the Valley Generating
Station (‘‘Valley Station’’), located in
Milwaukee, Wisconsin, from coal to
natural gas; and (2) to simplify the
process of terminating the Third
Amended Decree after December 31,
2015. The coal-to-natural-gas conversion
will provide significant emission
reductions at the Valley Station, and the
VerDate Mar<15>2010
19:25 Jul 11, 2014
Jkt 232001
termination-related changes will
provide greater finality for the
Defendant while also ensuring that the
Decree’s provisions remain enforceable
in the future through federally
enforceable state operating permits.
The publication of this notice opens
a period for public comment on
Proposed Third Amended Consent
Decree. Comments should be addressed
to the Acting Assistant Attorney
General, Environment and Natural
Resources Division, and should refer to
United States et al. v. Wisconsin Electric
Power Company, D.J. Ref. No. 90–5–2–
1–07493. All comments must be
submitted no later than thirty (30) days
after the publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .........
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington,
DC 20044–7611.
By mail ...........
During the public comment period,
the Joint Stipulation to Modify Section
XXI of the Amended Consent Decree
may be examined and downloaded at
this Justice Department Web site: https://
www.usdoj.gov/enrd/Consent_
Decrees.html. We will provide a paper
copy of the Proposed Third Amended
Consent Decree upon written request
and payment of reproduction costs.
Please mail your request and payment
to: Consent Decree Library, U.S. DOJ—
ENRD, P.O. Box 7611, Washington, DC
20044–7611.
Please enclose a check or money order
for $21.75 (25 cents per page
reproduction cost) payable to the United
States Treasury.
Thomas P. Carroll,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2014–16334 Filed 7–11–14; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration: Meridian Medical
Technologies
ACTION:
Notice of registration.
Meridian Medical
Technologies applied to be registered as
SUMMARY:
PO 00000
Frm 00076
Fmt 4703
Sfmt 9990
an importer of a certain basic class of
narcotic controlled substance. The DEA
grants Meridian Medical Technologies
registration as an importer of this
controlled substance.
By notice
dated April 21, 2014, and published in
the Federal Register on April 28, 2014,
79 FR 23374, Meridian Medical
Technologies, 2555 Hermelin Drive, St.
Louis, Missouri 63144, applied to be
registered as an importer of a certain
basic class of controlled substance. No
comments or objections were submitted
for this notice.
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the
registration of Meridian Medical
Technologies to import the basic class of
controlled substance is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of morphine (9300), a basic
class of narcotic controlled substance
listed in schedule II.
The company manufactures a product
containing morphine in the United
States. The company exports this
product to customers around the world.
The company has been asked to ensure
that its product, which is sold to
European customers, meets the
standards established by the European
Pharmacopeia, administered by the
Directorate for the Quality of Medicines
(EDQM). In order to ensure that its
product will meet European
specifications, the company seeks to
import morphine supplied by EDQM for
use as reference standards.
This is the sole purpose for which the
company will be authorized by the DEA
to import morphine.
SUPPLEMENTARY INFORMATION:
Dated: July 7, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–16318 Filed 7–11–14; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\14JYN1.SGM
14JYN1
]]>Agencies
[Federal Register Volume 79, Number 134 (Monday, July 14, 2014)]
[Notices]
[Page 40780]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-16318]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration: Meridian Medical
Technologies
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Meridian Medical Technologies applied to be registered as an
importer of a certain basic class of narcotic controlled substance. The
DEA grants Meridian Medical Technologies registration as an importer of
this controlled substance.
SUPPLEMENTARY INFORMATION: By notice dated April 21, 2014, and
published in the Federal Register on April 28, 2014, 79 FR 23374,
Meridian Medical Technologies, 2555 Hermelin Drive, St. Louis, Missouri
63144, applied to be registered as an importer of a certain basic class
of controlled substance. No comments or objections were submitted for
this notice.
The Drug Enforcement Administration (DEA) has considered the
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the
registration of Meridian Medical Technologies to import the basic class
of controlled substance is consistent with the public interest and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. The DEA investigated the company's
maintenance of effective controls against diversion by inspecting and
testing the company's physical security systems, verifying the
company's compliance with state and local laws, and reviewing the
company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above-named company is granted
registration as an importer of morphine (9300), a basic class of
narcotic controlled substance listed in schedule II.
The company manufactures a product containing morphine in the
United States. The company exports this product to customers around the
world. The company has been asked to ensure that its product, which is
sold to European customers, meets the standards established by the
European Pharmacopeia, administered by the Directorate for the Quality
of Medicines (EDQM). In order to ensure that its product will meet
European specifications, the company seeks to import morphine supplied
by EDQM for use as reference standards.
This is the sole purpose for which the company will be authorized
by the DEA to import morphine.
Dated: July 7, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-16318 Filed 7-11-14; 8:45 am]
BILLING CODE 4410-09-P
